Zura Bio Limited (ZURA) Stock Ticker
ZURA right now
Market factors today
Unlock the full ZURA picture
About Zura Bio Limited
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
ZURA stock facts
| Ticker symbol | ZURA |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $383.8M |
| CEO | Sandeep C. Kulkarni |
| Employees | 40 |
| Headquarters | Henderson, NV, US |
| IPO date | 2023-03-21 |
| Website | zurabio.com |
What you can see for ZURA on Tickr
Live ZURA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ZURA report.
Rankings
FAQ
What is the ticker symbol for Zura Bio Limited?
The ticker symbol for Zura Bio Limited is ZURA, listed on the NASDAQ Capital Market.
What is ZURA?
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a…